Search Results - "Damek, D."

Hypofractionated–Intensity Modulated Radiation Therapy (Hypo-IMRT) and Temozolomide (TMZ) With and Without Bevacizumab (BEV) for Glioblastoma Multiforme (GBM): A Comparison of 2 Prospective Phase 2 Trials by Carlson, J.A, Reddy, K, Gaspar, L.E, Ney, D, Kavanagh, B.D, Damek, D, Lillehei, K.O, Chen, C

Get full text

A Phase 2 Trial of Hypofractionated–Intensity Modulated Radiation Therapy (Hypo-IMRT) Combined With Temozolomide (TMZ) and Bevacizumab (BEV) for Patients With Newly Diagnosed Glioblastoma Multiforme (GBM) by Carlson, J.A, Ney, D, Reddy, K, Gaspar, L.E, Kavanagh, B.D, Damek, D, Lillehei, K.O, Chen, C

Get full text

Hypofractionated Intensity Modulated Radiation Therapy Altered Patterns of Failure in Patients With Glioblastoma Multiforme Treated on a Phase II Trial by Reddy, K, Damek, D, Gaspar, L.E, Ney, D, Kavanagh, B.D, Waziri, A, Lillehei, K, Stuhr, K, Chen, C

Get full text

Phase II Trial of Hypofractionated Intensity Modulated Radiotherapy to 60 Gy in 10 Fractions with Temozolomide Chemotherapy for Patients with Newly Diagnosed Glioblastoma Multiforme by Reddy, K, Damek, D, Gaspar, L, Ney, D, Kavanagh, B, Waziri, A, Lillehei, K, Stuhr, K, Chen, C

Get full text

Factors associated with survival in patients with meningioma by MCCARTHY, B. J, DAVIS, F. G, FREELS, S, SURAWICZ, T. S, DAMEK, D. M, GRUTSCH, J, MENCK, H. R, LAWS, E. R

“…To explore factors affecting the survival rate in patients with meningiomas, the authors used the National Cancer Data Base (NCDB), which includes tumors from…”
Get full text

Aspergillus terreus brain abscess mimicking tumor progression in a patient with treated glioblastoma multiforme by Damek, D M, Lillehei, K O, Kleinschmidt-DeMasters, B K

“…To detail a case of Aspergillus terreus brain abscess in a patient undergoing treatment for malignant glioma. Central nervous system aspergillosis usually…”
Get more information

Favorable Prognosis in Patients with High-Grade Glioma with Radiation Necrosis: The University of Colorado Denver Re-operation Series by Rusthoven, K.E, Olsen, C, Franklin, W, Kleinschmidt-DeMasters, B, Kavanagh, B.D, Gaspar, L.E, Lillehei, K, Waziri, A, Damek, D, Chen, C

Get full text

A Phase I Dose per Fraction Escalation Study of Hypofractionated Intensity-modulated Radiation Therapy with Temozolomide Chemotherapy for Patients with Newly Diagnosed Glioblastoma by Chen, C, Damek, D, Waziri, A, Gaspar, L.E, Lillehei, K, Kane, M, Robischon, M, Kavanagh, B

Get full text

Magnetic Resonance Imaging (MRI) T1 and T2 Volumetric Changes and their Implications after Hypofractionated Stereotactic Radiotherapy (SRS) in Patients with Recurrent Malignant Gliomas by Schwer, A, McCammon, R, Kavanagh, B, Gaspar, L, Damek, D, Chen, C

Get full text

Pregnancy and multiple sclerosis by Damek, D M, Shuster, E A

“…In this review, we summarize the available information on the short- and long-term effects of pregnancy on the course of multiple sclerosis (MS). Published…”
Get more information

Ongoing Clinical Trials by Clarke, J. L., Ennis, M. M., Lamborn, K. R., Prados, M. D., Puduvalli, V. K., Penas-Prado, M., Gilbert, M. R., Groves, M. D., Hess, K. R., Levin, V. A., de Groot, J., Colman, H., Conrad, C. A., Loghin, M. E., Hunter, K., Yung, W. K., Chen, C., Damek, D., Liu, A., Gaspar, L. E., Waziri, A., Lillehei, K., Kavanagh, B., Finlay, J. L., Haley, K., Dhall, G., Gardner, S., Allen, J., Cornelius, A., Olshefski, R., Garvin, J., Pradhan, K., Etzl, M., Goldman, S., Atlas, M., Thompson, S., Hirt, A., Hukin, J., Comito, M., Bertolone, S., Torkildson, J., Joyce, M., Moertel, C., Letterio, J., Kennedy, G., Walter, A., Ji, L., Sposto, R., Dorris, K., Wagner, L., Hummel, T., Drissi, R., Miles, L., Leach, J., Chow, L., Turner, R., Gragert, M. N., Pruitt, D., Sutton, M., Breneman, J., Crone, K., Fouladi, M., Friday, B. B., Buckner, J., Anderson, S. K., Giannini, C., Kugler, J., Mazurczac, M., Flynn, P., Gross, H., Pajon, E., Jaeckle, K., Galanis, E., Badruddoja, M. A., Pazzi, M. A., Stea, B., Lefferts, P., Contreras, N., Bishop, M., Seeger, J., Carmody, R., Rance, N., Marsella, M., Schroeder, K., Sanan, A., Swinnen, L. J., Rankin, C., Rushing, E. J., Hutchins, L. F., Damek, D. M., Barger, G. R., Norden, A. D., Lesser, G., Hammond, S. N., Drappatz, J., Fadul, C. E., Batchelor, T. T., Quant, E. C., Beroukhim, R., Ciampa, A.

Get full text

280O Pharmacokinetics and pharmacodynamics of paxalisib in newly diagnosed glioblastoma patients with unmethylated MGMT promoter status: Final phase II study results by Wen, P., de Groot, J.F., Battiste, J., Goldlust, S., Damek, D., Ellingson, B., Garner, J., Friend, J., Simpson, J., Olivero, A., Cloughesy, T.

Get full text

Neurolymphomatosis by Baehring, Joachim M, Damek, Denise, Martin, Emily C, Betensky, Rebecca A, Hochberg, Fred H

“…The term "neurolymphomatosis" (NL) has included infiltration of the peripheral nervous system by lymphoma and nontumor lymphocytes. We describe NL as a…”
Get full text

Clinical aspects of brain tumor by Damek, D M, Hochberg, F H

“…New approaches to treating patients with malignant brain tumors use advanced magnetic resonance and positron imaging. Clinical protocols to treat…”
Get more information

RT-24 EXTENT OF CEREBRAL RADIONECROSIS IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) TREATED ON A CLINICAL TRIAL WITH HYPOFRACTIONATED INTENSITY-MODULATED RADIATION THERAPY (HYPO-IMRT) COMBINED WITH TEMOZOLOMIDE (TMZ) AND BEVACIZUMAB (BEV) by Ney, D., Kleinschmidt-DeMasters, B. K., Carlson, J., Damek, D., Gaspar, L., Kavanagh, B., Waziri, A., Lillehei, K., Reddy, K., Chen, C.

“…BACKGROUND: Hypofractionated RT schemes may result in increased occurrence of clinically-significant radionecrosis (CSRN), but this potentially might be…”
Get full text

Phase II study of hydroxyurea for unresectable meningioma (Southwest Oncology Group S9811) by Swinnen, L. J., Rankin, C., Rushing, E. J., Laura, H. F., Damek, D. M., Barger, G. R.

“…Abstract only 2063 Background: Meningiomas account for 15%-18% of CNS tumors. Although benign, recurrence is seen in 16%-39% of cases, depending on the extent…”
Get full text

Intravenous methotrexate as initial treatment for primary central nervous system lymphoma: Response to therapy and quality of life of patients by GUHA-THAKURTA, N, DAMEK, D, POLLACK, C, HOCHBERG, F. H

“…In anticipation of a consortium study of methotrexate (MTX) therapy provided to patients with primary central nervous system lymphoma (PCNSL) we have provided…”
Get full text

RADIATION THERAPY by Behera, M. K., Sharma, A., Dutta, S., Sharma, S., Julka, P. K., Rath, G. K., Kil, W. J., Ko, C., Kaushal, A., Warran, K., Ning, H., Camphausen, K., Smart, D., Vern-Gross, T. Z., McMullen, K. P., Case, L. D., Bourland, J. D., Ellis, T. L., Lawrence, J. A., Tatter, S. B., Shaw, E. G., Urbanic, J. J., Chan, M. D., Jensen, R. L., Shrieve, D. C., Mohindra, P., Robins, H. I., Tome, W. A., Howard, S. P., Chen, C., Damek, D., Gaspar, L. E., Ney, D., Waziri, A., Lillehei, K., Kavanagh, B. D., Wang, C.-C., Floyd, S., Chang, C.-H., Warnke, P., Chio, C.-C., Kasper, E., Mahadevan, A., Wong, E., Jeyapalan, S., Mahajan, A., Grosshans, D., McAleer, M. F., Brown, P. D., Chintagumpala, M., Vats, T., Puduvalli, V., Yock, T., Schulder, M., Herschmann, Y., Ghaly, M., Knisely, J., Kapur, A., Goetz, P., Lwu, S., Ebinu, J., Arayee, M., Monsalves, E., Laperriere, N., Menard, C., Bernstein, M., Zadeh, G., Loganathan, A. G., Alphonse, N., Peiffer, A. M., Johnson, A., Saconn, P. A., Munley, M. T., Aryaee, M., Lowe, C., DeGroot, J., Mark, G., Ruda, R., Trevisan, E., Magliola, U., Bertero, L., Bosa, C., Ricardi, U., Soffietti, R., Rajappa, P., Margetis, K., Wernicke, A. G., Sherr, D. L., Lavi, E., Fine, R. L., Schwartz, T., Pannullo, S. C., Laack, N., Blanchard, M., Buckner, J., Glass, J., Andrews, D. W., Werner-Wasik, M., Evans, J., Lawrence, Y. R.

Get full text

Radiation Therapy by Charkravarti, A., Wang, M., Robins, I., Guha, A., Curren, W., Brachman, D., Schultz, C., Choucair, A., Dolled-Filhart, M., Christiansen, J., Gustavson, M., Molinaro, A., Mischel, P., Lautenschlaeger, T., Dicker, A., Mehta, M., Phillips, C. A., Dhulibala, S., Hallahan, D., Jaboin, J., Cardinale, F. S., Dickey, P., Goodrich, I., Gorelick, J., Sinha, R., Dest, V. M., Chen, C., Olsen, C., Franklin, W., Kleinschmidt-DeMasters, B., Kavanagh, B. D., Lillehei, K., Waziri, A., Damek, D., Gaspar, L. E., Stauder, M. C., Laack, N. N., Link, M. J., Pollock, B. E., Schomberg, P. J., Fraser, J. F., Pannullo, S. C., Moliterno, J., Cobb, W., Stieg, P. E., Vinchon-Petit, S., Jarnet, D., Michalak, S., Lewis, A., Benoit, J.-P., Menei, P., Desmarais, G., Paquette, B., Bujold, R., Mathieu, D., Fortin, D., Cuneo, K. C., Vredenburgh, J. J., Sampson, J. H., Reardon, D. A., Desjardins, A., Peters, K. L., Kirkpatrick, J. P., Patel, P. N., Vyas, R., Suryanarayan, U., Bhavsar, D., Hayhurst, C., Monsalves, E., Van Prooijen, M., Menard, C., Zadeh, G., Chung, C., Burrell, K., Lindsey, P., Burri, S. H., Asher, A. L., Kelly, R. B., Boltes, P., Fraser, R. W., Dilmanian, F. A., Rusek, A., Desnoyers, N. R., Park, J. Y., Dane, B., Dioszegi, I., Hurley, S. D., O'Banion, M. K., Tomasi, D., Wang, R., Meek, A. G., Sleire, L., Wang, J., Heggdal, J., Pedersen, P.-H., Enger, P. O., Clump, D. A., Srinivas, R., Wegner, R. E., Heron, D. E.

Get full text

Gliomatosis cerebri: Neurobehavioral and neuropathological observations by FILLEY, Christopher M, KLEINSCHMIDT-DEMASTERS, B. K, LILLEHEI, Kevin O, DAMEK, Denise M, HARRIS, Josette G

“…Gliomatosis cerebri is a rare neoplasm in which individual neoplastic cells diffusely permeate the brain; a cohesive tumor mass may appear late in the disease…”
Get full text